Ginger Nicol, MD, CEDS, Dipl. ABOM - Psychiatry (original) (raw)
Associate Professor of Psychiatry
Additional Titles & Roles
- Director, Child and Adolescent Psychiatry Residency Research Education Program (CAP-PRREP)
- Director, Digital and Health Integrative Research, Employee and Family Mental Health & Wellness Center
- Director, Mobile Health Research Core (MHRC)
- Co-Director, Healthy Mind Lab
Education & Training
- Postdoctoral Training: NIDA Research Fellowship: Biomedical Research Training in Drug Abuse, 2010
- Fellowship: Child & Adolescent Psychiatry: Washington University, St. Louis, MO, 2007
- Residency: Washington University, St. Louis, MO, 2005
- MD: University of Iowa, Iowa City, IA, 2002
- BA: Journalism & Mass Communications: University of Iowa, Iowa City, IA, 1998
- Obesity Medicine Board Certification: American Board of Obesity Medicine, 2020
Major Awards
- Eli Robins Award for Excellence in Clinical Psychiatry, Teaching and Research, 2007
- Mortimer Goodman Award for Outstanding Contribution to Mental Health through MO NAMI, 2014
- Resident Mentoring Award, Washington University School of Medicine, Department of Psychiatry, 2018
- Child Fellowship Mentoring Award, Washington University School of Medicine, Department of Psychiatry, 2019
Areas of Clinical Interest
Obesity and metabolic health in children, adults and older adults with severe mental illness; eating disorders; medical weight management.
Research Interests
Identification and prevention of cardiometabolic risk in mentally ill populations, psychopharmacology, medical and behavioral treatment of obesity and eating disorders in children, adults and older adults.
Key Publications
- Nicol GE, Yingling MD, Flavin KS, Schweiger JA, Patterson BW, Schechtman KB, Newcomer JW, (2018 Jun). Metabolic Effects of Antipsychotics on Adiposity and Insulin Sensitivity in Youths: A Randomized Clinical Trial. JAMA Psychiatry.
Read publication » - Nicol GE, de Las Fuentes L, Riek AE, Bernal-Mizrachi C, Lenze EJ, Miller JP, Schweiger JA, Yingling MD, Huang VJ, Dixon DJ, Hennekens CH, Newcomer JW, (2015 Sep).Adiposity and Cardiometabolic Risk in Children With and Without Antipsychotic Drug Treatment.J. Clin. Endocrinol. Metab.. 100(9): 3418-26.
Read publication »Adiposity and Cardiometabolic Risk in Children With and Without Antipsychotic Drug Treatment. - Morrato EH, Nicol GE, Maahs D, Druss BG, Hartung DM, Valuck RJ, Campagna E, Newcomer JW, (2010 Apr).Metabolic screening in children receiving antipsychotic drug treatment.Arch Pediatr Adolesc Med. 164(4): 344-51.
Read publication »Metabolic screening in children receiving antipsychotic drug treatment. - Nicol GE, Morrato EH, Johnson MC, Campagna E, Yingling MD, Pham V, Newcomer JW. Best practices: implementation of a glucose screening program based on diffusion of innovation theory methods. Psychiatr Serv. 2011 Jan;62(1):12-4.
Read publication »Best practices: implementation of a glucose screening program based on diffusion of innovation theory methods. - Altered gray matter volume and school age anxiety in children born late preterm. Rogers CE, Barch DM, Sylvester CM, Pagliaccio D, Harms MP, Botteron KN, Luby JL J Pediatr. 2014 Nov; 165(5)928-35. doi: 10.1016/j.jpeds.2014.06.063.
- Nicol GE, Campagna EJ, Garfield LD, Newcomer JW, Parks JJ, Morrato EH, (2016 Jan).The Role of Clinical Setting and Management Approach in Metabolic Testing Among Youths and Adults Treated With Antipsychotics.Psychiatr Serv. 67(1): 128-32.
Read publication »The Role of Clinical Setting and Management Approach in Metabolic Testing Among Youths and Adults Treated With Antipsychotics.
Funded Research Projects
Nutrition & Obesity Research Center(PI):Metabolic Effects of Metformin in Obese Antipsychotic Treated Youth
NIAMSD(Significant Contributor):Purposeful Understanding of Molecular Mechanisms in Pediatric Exercise Discovery (PUMMPED)
NICHD(PI):3/4-Metformin in Youths with Antipsychotic-related Weight Gain
Patient-Centered Outcomes Research Institute(Significant Contributor):Genetics and Patient-Centered Outcomes Research (G-PCOR) Web Portal
Patient-Centered Outcomes Research Institute(Significant Contributor):Bringing Data about Genetic Susceptibility Factors to Outcome Researchers Through Engaging Stakeholders: The Bridge Project
National Eating Disorders Association(PI):Establishing and implementing a research infrastructure for eating disorders in a clinical setting
Children’s Discovery Institute(Significant Contributor):Genetic, molecular, and socio-behavioral data for precision medicine in adolescent bariatric surgery
Patient-Centered Outcomes Research Institute(Significant Contributor):Optimizing Outcomes in Treatment-Resistant Depression in Older Adults
Alkermes, Inc.(PI):A Phase 3 Study to Assess the Long Term Safety, Tolerability, and Durability of Treatment Effect of ALKS 3831 in Subjects with Schizophrenia, Schizophreniform Disorder, or Bipolar I Disorder
NIMH(Significant Contributor):Discovery and CRISPR validation of genetic factors associated with antipsychotic-induced weight gain and cardiometabolic risk
ICTS(PI):Intermittent Fasting in Obese Adolescents with Neurodevelopmental Disorder
NIH(Significant Contributor):PRomoting OptiMIzed methodS to rEduce cardiometabolic risk (PROMISE)
ICTS(PI):Ecological Daily Needs Assessment for Behavioral Weight Loss in Mentally Ill Kids
NIDDK(Significant Contributor):Psychological influences on obesogenic behaviors among healthcare workers: Impact on weight and intervention efficacy
NIMH(PI):Age-dependent CRISPR-measured Effects of Antipsychotics on Adiposity
NCATS(Significant Contributor):Washington University Institute of Clinical and Translational Sciences: Network Capacity – Liaison to Trial Innovation Centers
NIMH(Significant Contributor):Adaptation of an Evidence-based Interactive Obesity Treatment Approach (iOTA) for Obesity Prevention in Early Serious Mental Illness: iOTAeSMI